Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:56 UTC |
---|
HMDB ID | HMDB0015326 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Flecainide |
---|
Description | Flecainide, also known as (+-)-flecainide or ccris 313, belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. In humans, flecainide is involved in the flecainide action pathway. Flecainide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Flecainide. |
---|
Structure | FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1 InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26) |
---|
Synonyms | Value | Source |
---|
(+-)-Flecainide | ChEBI | CCRIS 313 | ChEBI | Flecaine | ChEBI | Flecainida | ChEBI | Flecainidum | ChEBI | N-(2-Piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide | ChEBI | Apocard | MeSH, HMDB | Flecainide monoacetate, (S)-isomer | MeSH, HMDB | Flecainide, 5-HO-N-(6-oxo)-derivative | MeSH, HMDB | Merck dura brand OF flecainide acetate | MeSH, HMDB | Alpharma brand OF flecainide acetate | MeSH, HMDB | Flecainide, 5-HO-N-(6-oxo)-derivative, (+-)-isomer | MeSH, HMDB | Flecatab | MeSH, HMDB | Tambocor | MeSH, HMDB | 3m Brand OF flecainide acetate | MeSH, HMDB | Alphapharm brand OF flecainide acetate | MeSH, HMDB | Flecadura | MeSH, HMDB | Flecainid-isis | MeSH, HMDB | Flecainide acetate | MeSH, HMDB | Flecainide monoacetate, (R)-isomer | MeSH, HMDB | Flecainide, (R)-isomer | MeSH, HMDB | Flecainide, (S)-isomer | MeSH, HMDB | Riker brand OF flecainide acetate | MeSH, HMDB | Acetate, flecainide | MeSH, HMDB | Flecainid isis | MeSH, HMDB | Flecainide monoacetate | MeSH, HMDB | Flecainide monoacetate, (+-)-isomer | MeSH, HMDB | United drug brand OF flecainide acetate | MeSH, HMDB |
| Show more...
---|
Chemical Formula | C17H20F6N2O3 |
---|
Average Molecular Weight | 414.3427 |
---|
Monoisotopic Molecular Weight | 414.137811746 |
---|
IUPAC Name | N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide |
---|
Traditional Name | flecainide |
---|
CAS Registry Number | 54143-55-4 |
---|
SMILES | FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1 |
---|
InChI Identifier | InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26) |
---|
InChI Key | DJBNUMBKLMJRSA-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Benzamides |
---|
Alternative Parents | |
---|
Substituents | - Benzamide
- Phenoxy compound
- Benzoyl
- Phenol ether
- Alkyl aryl ether
- Piperidine
- Amino acid or derivatives
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Secondary aliphatic amine
- Ether
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Organohalogen compound
- Alkyl halide
- Alkyl fluoride
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.032 g/L | Not Available | LogP | 4.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 192.2 | 30932474 |
|
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Flecainide,1TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2206.6 | Semi standard non polar | 33892256 | Flecainide,1TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2328.9 | Standard non polar | 33892256 | Flecainide,1TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2439.0 | Standard polar | 33892256 | Flecainide,1TMS,isomer #2 | C[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2337.9 | Semi standard non polar | 33892256 | Flecainide,1TMS,isomer #2 | C[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2298.8 | Standard non polar | 33892256 | Flecainide,1TMS,isomer #2 | C[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2621.5 | Standard polar | 33892256 | Flecainide,2TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2316.7 | Semi standard non polar | 33892256 | Flecainide,2TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2424.8 | Standard non polar | 33892256 | Flecainide,2TMS,isomer #1 | C[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2483.5 | Standard polar | 33892256 | Flecainide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2378.4 | Semi standard non polar | 33892256 | Flecainide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2561.6 | Standard non polar | 33892256 | Flecainide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2526.8 | Standard polar | 33892256 | Flecainide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2520.1 | Semi standard non polar | 33892256 | Flecainide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2504.2 | Standard non polar | 33892256 | Flecainide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1CCCCC1CNC(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2687.1 | Standard polar | 33892256 | Flecainide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C(C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2692.2 | Semi standard non polar | 33892256 | Flecainide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C(C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2805.9 | Standard non polar | 33892256 | Flecainide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CC1CCCCN1[Si](C)(C)C(C)(C)C)C(=O)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F | 2671.7 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Flecainide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f89-5009000000-7b1564870deda7f2d21e | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flecainide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flecainide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flecainide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Flecainide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-001i-9000000000-b732167df77d39193144 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-00dl-0095000000-644485d209c90776a32d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-00di-0190000000-201f2152d161a1ff83e5 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-00di-0790000000-928874c4b348381ad1b8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-0596-0940000000-ee7a94ba0d7bcfa2fe93 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-052g-1910000000-a32ac2f605f11fbbc5e0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , negative-QTOF | splash10-0297-1900000000-f1c49d25a6b161ff44d9 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 30V, Negative-QTOF | splash10-00di-0090000000-8d4a6a9978cccc816b47 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 15V, Negative-QTOF | splash10-00dl-0095000000-43e08367bbe8d04a6a08 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 60V, Negative-QTOF | splash10-0596-0940000000-8c3aff3bc24541d8739d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 20V, Negative-QTOF | splash10-00dl-0090000000-7b5a76e5b473705a0de5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 10V, Negative-QTOF | splash10-03k9-0007900000-c01a08b2f11aa54d8718 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 45V, Negative-QTOF | splash10-00di-0790000000-d9ff0b268b85eaeda91c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 40V, Negative-QTOF | splash10-00di-0090000000-b1e686e3fcae67c0c6a0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 30V, Negative-QTOF | splash10-00di-0190000000-8de6d230a8cd23c50272 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-014i-0000900000-9820e909cb01d45fa815 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-00kb-2009500000-68b872fada8afdd4e580 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-0f6t-5019000000-8fa5e4257c88beda0ea1 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-0uea-8069000000-149a79cf429446ec77c2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-0uei-6292000000-103ccdef98c4b6c9e408 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide LC-ESI-QFT , positive-QTOF | splash10-0pdi-8970000000-9258d139b203d6c98df0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 15V, Positive-QTOF | splash10-014i-0000900000-3df851e0ff354ab1be59 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 30V, Positive-QTOF | splash10-00kb-2009500000-c58556b6a88ebc0729bc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 20V, Positive-QTOF | splash10-014i-0001900000-9830e722af2fab717f28 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 10V, Positive-QTOF | splash10-014i-0000900000-c80ce9de474de184ff13 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Flecainide 45V, Positive-QTOF | splash10-0f6t-5019000000-00737a572b9aa2cd61a3 | 2021-09-20 | HMDB team, MONA | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01195 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB01195 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 uM | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities | Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB01195 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 3239 |
---|
KEGG Compound ID | C07001 |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Flecainide |
---|
METLIN ID | Not Available |
---|
PubChem Compound | Not Available |
---|
PDB ID | Not Available |
---|
ChEBI ID | 75984 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Gill JS, Mehta D, Ward DE, Camm AJ: Efficacy of flecainide, sotalol, and verapamil in the treatment of right ventricular tachycardia in patients without overt cardiac abnormality. Br Heart J. 1992 Oct;68(4):392-7. [PubMed:1449923 ]
- Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, et al.: Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781-8. [PubMed:1900101 ]
- Sakurada H, Hiyoshi Y, Tejima T, Yanase O, Tokuyasu Y, Watanabe K, Motomiya T, Sugiura M, Hiraoka M: [Effects of oral flecainide treatment of refractory tachyarrhythmias]. Kokyu To Junkan. 1990 May;38(5):471-6. [PubMed:2115193 ]
- Greenberg HM, Dwyer EM Jr, Hochman JS, Steinberg JS, Echt DS, Peters RW: Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J. 1995 Dec;74(6):631-5. [PubMed:8541168 ]
- Gasparini M, Priori SG, Mantica M, Napolitano C, Galimberti P, Ceriotti C, Simonini S: Flecainide test in Brugada syndrome: a reproducible but risky tool. Pacing Clin Electrophysiol. 2003 Jan;26(1 Pt 2):338-41. [PubMed:12687841 ]
|
---|